Pathologic and gene expression features of metastatic melanomas to the brain-Reference-Cited by-同舟云学术

Pathologic and gene expression features of metastatic melanomas to the brain

Published:2013-05-21 Issue:15 Volume:119 Page:2737-2746
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Hamilton Ronald¹,Krauze Michal²,Romkes Marjorie²,Omolo Bernard³,Konstantinopoulos Panagiotis⁴,Reinhart Todd⁵,Harasymczuk Malgorzata⁶,Wang YangYang⁶⁷,Lin Yan⁸,Ferrone Soldano⁶⁷,Whiteside Theresa⁶,Bortoluzzi Stephanie¹,Werley Jonette¹,Nukui Tomoko²,Fallert-Junecko Beth⁵,Kondziolka Douglas⁹,Ibrahim Joseph¹⁰,Becker Dorothea¹,Kirkwood John²,Moschos Stergios²¹¹

Affiliation:

1. Department of Pathology; University of Pittsburgh; Pittsburgh Pennsylvania

2. Department of Medicine; University of Pittsburgh; Pittsburgh Pennsylvania

3. Division of Mathematics and Computer Science; University of South Carolina Upstate; Spartanburg South Carolina

4. Department of Medicine; Beth Israel Deaconess Medical Center, Harvard Medical School; Boston Massachusetts

5. Department of Infectious Diseases and Microbiology; Graduate School of Public Health; University of Pittsburgh; Pittsburgh Pennsylvania

6. Department of Immunology; University of Pittsburgh; Pittsburgh Pennsylvania

7. Department of Surgery; University of Pittsburgh; Pittsburgh Pennsylvania

8. Biostatistics Facility; University of Pittsburgh Cancer Institute; Pittsburgh Pennsylvania

9. Department of Neurological Surgery; University of Pittsburgh; Pittsburgh Pennsylvania

10. Department of Biostatistics; University of North Carolina School of Global Public Health; Chapel Hill North Carolina

11. Department of Medicine; University of North Carolina at Chapel Hill; North Carolina

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28029/fullpdf

Reference27 articles.

1. Brain metastases: pathobiology and emerging targeted therapies;Preusser;Acta Neuropathol,2012

2. Prognostic factors for survival in melanoma patients with brain metastases;Davies;Cancer,2011

3. Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial;Long;Lancet Oncol,2012

4. Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial;Margolin;Lancet Oncol,2012

5. NRAS mutation status is an independent prognostic factor in metastatic melanoma;Jakob;Cancer,2012

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Morpho-phenotypic characterization of melanoma brain metastases immune microenvironment: A multicentre retrospective study;EJC Skin Cancer;2024

2. Impact of prior systemic therapy on lymphocytic infiltration in surgically resected breast cancer brain metastases;Breast Cancer Research and Treatment;2023-03-17

3. PD-L1 expression in 117 sinonasal mucosal melanomas and its association with clinical outcome;Annals of Diagnostic Pathology;2022-10

4. Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities;Pigment Cell & Melanoma Research;2022-09

5. The role of systemic therapy in melanoma brain metastases: a narrative review;Chinese Clinical Oncology;2022-06